AA
LONA

AlphaCentric Advisors’s LeonaBio Inc LONA Stock Holding History

AlphaCentric Advisors’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$268K Hold
2,054
– – 0.08% 87
2021
Q3 		$193K Hold
2,054
– – 0.05% 112
2021
Q2 		$210K Hold
2,054
– – 0.06% 105
2021
Q1 		$378K Buy
+2,054
New +$453K 0.13% 59

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

AlphaCentric Advisors's LONA Position: Q4 2021 in Review

AlphaCentric Advisors held its LeonaBio Inc (LONA) position steady in Q4 2021 at 2,054 shares worth $268K. The position accounts for 0.08% of the portfolio, ranked #87.

AlphaCentric Advisors first reported a position in LONA in Q1 2021 and has held it in 4 quarters since. The position peaked at $378K in Q1 2021. 103 funds tracked by Wall St. Rank hold LONA as of Q4 2021.

  • AlphaCentric Advisors held 2,054 shares of LeonaBio Inc worth $268K as of Q4 2021.
  • AlphaCentric Advisors left its LeonaBio Inc share count unchanged in Q4 2021.
  • LeonaBio Inc made up 0.08% of AlphaCentric Advisors's portfolio in Q4 2021, its #87 holding.
  • AlphaCentric Advisors first reported a position in LeonaBio Inc in Q1 2021 and has held it in 4 quarters since.
  • AlphaCentric Advisors's LeonaBio Inc position peaked at $378K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2021.

Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.